Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Claire Corcoran"'
Autor:
Elza C de Bruin, Jessica L Whiteley, Claire Corcoran, Pauline M Kirk, Jayne C Fox, Javier Armisen, Justin P O Lindemann, Gaia Schiavon, Helen J Ambrose, Alexander Kohlmann
Publikováno v:
PLoS ONE, Vol 12, Iss 5, p e0175779 (2017)
Personalized healthcare relies on accurate companion diagnostic assays that enable the most appropriate treatment decision for cancer patients. Extensive assay validation prior to use in a clinical setting is essential for providing a reliable test r
Externí odkaz:
https://doaj.org/article/3e485ea657ce4bf09a2d0717817f9dbd
Autor:
James L Sherwood, Claire Corcoran, Helen Brown, Alan D Sharpe, Milena Musilova, Alexander Kohlmann
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0150197 (2016)
INTRODUCTION:Non-invasive mutation testing using circulating tumour DNA (ctDNA) is an attractive premise. This could enable patients without available tumour sample to access more treatment options. MATERIALS & METHODS:Peripheral blood and matched tu
Externí odkaz:
https://doaj.org/article/3b34ba32962d4e4ea7e1331d4627d8f2
Autor:
Claire Corcoran, Sweta Rani, Keith O'Brien, Amanda O'Neill, Maria Prencipe, Rizwan Sheikh, Glenn Webb, Ray McDermott, William Watson, John Crown, Lorraine O'Driscoll
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e50999 (2012)
BackgroundHormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may be transferred from cell-to-cell v
Externí odkaz:
https://doaj.org/article/a97c7c2322af4f1b9e2ae08a87e51550
Autor:
Kim N. Chi, Alan Barnicle, Caroline Sibilla, Zhongwu Lai, Claire Corcoran, J. Carl Barrett, Carrie A. Adelman, Ping Qiu, Ashley Easter, Simon Dearden, Geoffrey R. Oxnard, Neeraj Agarwal, Arun Azad, Johann de Bono, Joaquin Mateo, David Olmos, Antoine Thiery-Vuillemin, Elizabeth A. Harrington
Publikováno v:
Scientia
Purpose: Not all patients with metastatic castration-resistant prostate cancer (mCRPC) have sufficient tumor tissue available for multigene molecular testing. Furthermore, samples may fail because of difficulties within the testing procedure. Optimiz
Autor:
Elizabeth A. Harrington, Antoine Thiery-Vuillemin, David Olmos, Joaquin Mateo, Johann de Bono, Arun Azad, Neeraj Agarwal, Geoffrey R. Oxnard, Simon Dearden, Ashley Easter, Ping Qiu, Carrie A. Adelman, J. Carl Barrett, Claire Corcoran, Zhongwu Lai, Caroline Sibilla, Alan Barnicle, Kim N. Chi
Supplementary Data from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49b80c4653e0a112e4f527cdf528960b
https://doi.org/10.1158/1078-0432.22489511.v1
https://doi.org/10.1158/1078-0432.22489511.v1
Autor:
Elizabeth A. Harrington, Antoine Thiery-Vuillemin, David Olmos, Joaquin Mateo, Johann de Bono, Arun Azad, Neeraj Agarwal, Geoffrey R. Oxnard, Simon Dearden, Ashley Easter, Ping Qiu, Carrie A. Adelman, J. Carl Barrett, Claire Corcoran, Zhongwu Lai, Caroline Sibilla, Alan Barnicle, Kim N. Chi
Supplementary Figure from Detection of BRCA1, BRCA2, and ATM Alterations in Matched Tumor Tissue and Circulating Tumor DNA in Patients with Prostate Cancer Screened in PROfound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19d5154ea363820d2a4c6b4547cf8579
https://doi.org/10.1158/1078-0432.22489499
https://doi.org/10.1158/1078-0432.22489499
Autor:
Elizabeth A. Harrington, Antoine Thiery-Vuillemin, David Olmos, Joaquin Mateo, Johann de Bono, Arun Azad, Neeraj Agarwal, Geoffrey R. Oxnard, Simon Dearden, Ashley Easter, Ping Qiu, Carrie A. Adelman, J. Carl Barrett, Claire Corcoran, Zhongwu Lai, Caroline Sibilla, Alan Barnicle, Kim N. Chi
Purpose:Not all patients with metastatic castration-resistant prostate cancer (mCRPC) have sufficient tumor tissue available for multigene molecular testing. Furthermore, samples may fail because of difficulties within the testing procedure. Optimiza
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81b6756b0eb67a2c94a85a2c40da3c04
https://doi.org/10.1158/1078-0432.c.6532970.v1
https://doi.org/10.1158/1078-0432.c.6532970.v1
Autor:
Johann de Bono, Christian Poehlein, Allison Allen, Carrie A. Adelman, Jinyu Kang, Julia A. Elvin, Robert Huisden, Alexander Kohlmann, Charles Padua, Young Deuk Choi, Craig Gedye, Nobuaki Matsubara, Mustafa Özgüroǧlu, Guilhem Roubaud, Michael P. Kolinsky, Niven Mehra, David Olmos, Joaquin Mateo, Shahneen Sandhu, Neal Shore, Fred Saad, Karim Fizazi, Caroline Sibilla, Claire Corcoran, Maha Hussain
Supplementary Figure from Tumor Genomic Testing for >4,000 Men with Metastatic Castration-resistant Prostate Cancer in the Phase III Trial PROfound (Olaparib)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16d8c245523421431a9963e0bfaf8fc9
https://doi.org/10.1158/1078-0432.22486373
https://doi.org/10.1158/1078-0432.22486373
Autor:
David M. Hyman, José Baselga, Sarat Chandarlapaty, Barry S. Taylor, Maurizio Scaltriti, Udai Banerji, Gaia Schiavon, Vicky Rowlands, Martin Pass, Michele Moschetta, Robert McEwen, Rhiannon Maudsley, Justin P.O. Lindemann, Joana Hauser, Andrew Foxley, Elza C. de Bruin, Claire Corcoran, Des D. Cashell, Alan Barnicle, Jack Ashton, Helen J. Ambrose, Laura Biganzoli, Marie-Paule Sablin, Ingrid A. Mayer, Eva M. Ciruelos, Mafalda Oliveira, Kenji Tamura, Lillian M. Smyth
Supplementary Figure 1. Participant Flow Diagram
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4f3ddb7682626f66115790cb0108aba
https://doi.org/10.1158/1078-0432.22476300.v1
https://doi.org/10.1158/1078-0432.22476300.v1
Autor:
Johann de Bono, Christian Poehlein, Allison Allen, Carrie A. Adelman, Jinyu Kang, Julia A. Elvin, Robert Huisden, Alexander Kohlmann, Charles Padua, Young Deuk Choi, Craig Gedye, Nobuaki Matsubara, Mustafa Özgüroǧlu, Guilhem Roubaud, Michael P. Kolinsky, Niven Mehra, David Olmos, Joaquin Mateo, Shahneen Sandhu, Neal Shore, Fred Saad, Karim Fizazi, Caroline Sibilla, Claire Corcoran, Maha Hussain
Purpose:Successful implementation of genomic testing in clinical practice is critical for identification of men with metastatic castration-resistant prostate cancer (mCRPC) eligible for olaparib and future molecularly targeted therapies.Patients and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0af4a5f059d9d09c98a4b55d79bc2c7e
https://doi.org/10.1158/1078-0432.c.6532301
https://doi.org/10.1158/1078-0432.c.6532301